DNA damage responses following exposure to modulated radiation fields.
During the delivery of advanced radiotherapy treatment techniques modulated beams are utilised to increase dose conformity across the target volume. Recent investigations have highlighted differential cellular responses to modulated radiation fields particularly in areas outside the primary treatment field that cannot be accounted for by scattered dose alone. In the present study, we determined the DNA damage response within the normal human fibroblast AG0-1522B and the prostate cancer cell line DU-145 utilising the DNA damage assay. Cells plated in slide flasks were exposed to 1 Gy uniform or modulated radiation fields. Modulated fields were delivered by shielding 25%, 50% or 75% of the flask during irradiation. The average number of 53BP1 or γH2AX foci was measured in 2 mm intervals across the slide area. Following 30 minutes after modulated radiation field exposure an increase in the average number of foci out-of-field was observed when compared to non-irradiated controls. In-field, a non-uniform response was observed with a significant decrease in the average number of foci compared to uniformly irradiated cells. Following 24 hrs after exposure there is evidence for two populations of responding cells to bystander signals in-and out-of-field. There was no significant difference in DNA damage response between 25%, 50% or 75% modulated fields. The response was dependent on cellular secreted intercellular signalling as physical inhibition of intercellular communication abrogated the observed response. Elevated residual DNA damage observed within out-of-field regions decreased following addition of an inducible nitric oxide synthase inhibitor (Aminoguanidine). These data show, for the first time, differential DNA damage responses in-and out-of-field following modulated radiation field delivery. This study provides further evidence for a role of intercellular communication in mediating cellular radiobiological response to modulated radiation fields and may inform the refinement of existing radiobiological models for the optimization of advanced radiotherapy treatment plans.
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.
Colman
C
Trainor
Karl T
KT
Butterworth
Conor K
CK
McGarry
Stephen J
SJ
McMahon
Joe M
JM
O'Sullivan
Alan R
AR
Hounsell
Kevin M
KM
Prise
D024201:Bystander Effect; D002450:Cell Communication / Q000528:radiation effects*; D045744:Cell Line, Tumor; D004249:DNA Damage / Q000235:genetics / Q000528:radiation effects*; D004260:DNA Repair / Q000502:physiology*; D005347:Fibroblasts; D006801:Humans; D008856:Microscopy, Fluorescence; D016012:Poisson Distribution; D011836:Radiation Tolerance; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects*